|
Personal data - diagnosis
|
Personal data
| Visible name: |
nocciolo |
| Ctry: |
Deutschland |
| State/Province: |
|
| Year of birth: |
1959 |
| Age: |
65 |
| Occupation: |
|
| Hobbies: |
|
| My Website: |
|
|
Data at initial diagnosis
| Date: |
29.09.2014 |
| Age at diagnosis: |
55 |
| PSA: |
36.50 |
| Biopsied? |
Yes |
| TUR-P? |
No |
| Gleason Score: |
4 + 3 = 7b |
| TNM-Stages: |
T2a |
| Remark: |
|
|
|
Maximum measured prostate volume
| Date: |
23.10.2014 |
| PSA: |
26.94 |
| Volume in ml or cm³: |
51ml |
|
Postoperative pathological data
| Date: |
|
| Gleason Score: |
4 + 3 = 7b |
| pTNM-classification: |
T3b pN1 ( cM0 |
| Margins: |
R1 |
| p-L-V-P-G-Findings: |
|
| See stories of: |
23.10.2014 |
|
|
Prostate cancer treatments
** PSA level at the start of the treatment
|
| from |
to |
PSA** |
Type |
Clinic |
City |
|
22.10.14 |
|
35.00 |
Open surgery |
Martini - Klinik |
Hamburg |
|
12.02.15 |
|
0.50 |
IMRT |
Markus-Krankenhaus |
Frankfurt |
|
20.02.20 |
|
707.80 |
ADT1 |
Eligard |
GRP-Rüsselsheim |
|
26.02.20 |
01.07.20 |
707.80 |
Chemotherapy |
6 x Docetaxel 18 Wochen |
GRP-Rüsselsheim |
|
20.08.20 |
22.10.20 |
10.80 |
Chemotherapy |
3 x Docetaxel 9 Wochen |
GRP-Rüsselsheim |
|
21.09.21 |
|
17.00 |
other ADT |
Zytiga |
GRP-Rüsselsheim |
|
29.04.24 |
|
72.50 |
other ADT |
Apalutamid |
Onkologie Nordwestkrankenhaus-Frankfurt |
|
26.08.24 |
|
92.30 |
other RT |
Radioligandentherapie Lu-177 |
Uniklinik Frankfurt |
|
21.10.24 |
|
75.40 |
other RT |
Radioligandentherapie Lu-177 |
Uniklinik Frankfurt |
|
02.12.24 |
|
74.30 |
other RT |
Radioligandentherapie Lu-177 |
Uniklinik Frankfurt |
|
01.02.25 |
|
73.10 |
other ADT |
Enzalutamid |
Onkologie Nordwestkrankenhaus-Frankfurt |
|
03.02.25 |
05.02.25 |
71.90 |
other RT |
Radioligandentherapie Lu 177 |
Uniklinik Frankfurt |
|
|
Drugs
NEM = Nutritional supplement
|
| from |
to |
Medication |
Quantity / unit of time |
|
21.09.21 |
29.04.24 |
Abirateron + Prednisolon 10mg |
|
|
20.12.22 |
|
XGEVA |
|
|
29.04.24 |
31.01.25 |
Apalutamid |
|
|
01.02.25 |
|
Enzalutamid |
|
Quantity per D / M / Y etc.
|
